Correlation Between NYSE Composite and Molecular Pharmacology
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Molecular Pharmacology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Molecular Pharmacology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Molecular Pharmacology, you can compare the effects of market volatilities on NYSE Composite and Molecular Pharmacology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Molecular Pharmacology. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Molecular Pharmacology.
Diversification Opportunities for NYSE Composite and Molecular Pharmacology
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between NYSE and Molecular is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Molecular Pharmacology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Pharmacology and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Molecular Pharmacology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Pharmacology has no effect on the direction of NYSE Composite i.e., NYSE Composite and Molecular Pharmacology go up and down completely randomly.
Pair Corralation between NYSE Composite and Molecular Pharmacology
Assuming the 90 days trading horizon NYSE Composite is expected to generate 81.54 times less return on investment than Molecular Pharmacology. But when comparing it to its historical volatility, NYSE Composite is 83.56 times less risky than Molecular Pharmacology. It trades about 0.08 of its potential returns per unit of risk. Molecular Pharmacology is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 0.01 in Molecular Pharmacology on November 9, 2024 and sell it today you would earn a total of 0.00 from holding Molecular Pharmacology or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 99.8% |
| Values | Daily Returns |
NYSE Composite vs. Molecular Pharmacology
Performance |
| Timeline |
NYSE Composite and Molecular Pharmacology Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Molecular Pharmacology
Pair trading matchups for Molecular Pharmacology
Pair Trading with NYSE Composite and Molecular Pharmacology
The main advantage of trading using opposite NYSE Composite and Molecular Pharmacology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Molecular Pharmacology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Pharmacology will offset losses from the drop in Molecular Pharmacology's long position.| NYSE Composite vs. Integrated Media Technology | NYSE Composite vs. Custom Truck One | NYSE Composite vs. Funko Inc | NYSE Composite vs. Multi Ways Holdings |
| Molecular Pharmacology vs. Curative Biotechnology | Molecular Pharmacology vs. Vertex Pharmaceuticals | Molecular Pharmacology vs. BioNTech SE | Molecular Pharmacology vs. Moderna |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Commodity Directory Find actively traded commodities issued by global exchanges |